6-o-stearoyl-n-acetylmuramyl-alanylisoglutamine has been researched along with E coli Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Matsumoto, K; Mitsuyama, M; Nomoto, K; Ogawa, H; Osada, Y; Otani, T; Une, T | 1 |
Matsumoto, K; Mitsuyama, M; Nomoto, K; Ogawa, H; Osada, Y; Otani, T; Satoh, M; Une, T | 1 |
2 other study(ies) available for 6-o-stearoyl-n-acetylmuramyl-alanylisoglutamine and E coli Infections
Article | Year |
---|---|
Stimulation of resistance of immunocompromised mice by a muramyl dipeptide analog.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Aging; Animals; Candidiasis; Escherichia coli Infections; Immunity, Innate; Immunosuppression Therapy; Male; Mice | 1982 |
Effect of L18-MDP(Ala), a synthetic derivative of muramyl dipeptide, on nonspecific resistance of mice to microbial infections.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Anti-Bacterial Agents; Bacterial Infections; Candidiasis; Drug Synergism; Escherichia coli Infections; Glycopeptides; Immunity, Innate; Klebsiella Infections; Klebsiella pneumoniae; Listeria monocytogenes; Listeriosis; Male; Mice; Phagocytosis; Staphylococcal Infections | 1982 |